Talphera (TLPH) Other Accumulated Expenses (2011 - 2025)
Talphera (TLPH) posted Other Accumulated Expenses of $34000.0 for Q4 2025, down 88.28% on a QoQ basis from $290000.0 in Q4 2024, and down 88.28% year-over-year from $290000.0 in Q4 2024.
Analysis
Talphera (TLPH) Other Accumulated Expenses (2011 - 2025) Analysis & Trends
Talphera has reported Other Accumulated Expenses for 13 years, with the latest figure at $34000.0 in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses fell 88.28% year-over-year to $34000.0 in Q4 2025; TTM through Dec 2025 was $34000.0, a 88.28% decrease from a year earlier, with the FY2025 full-year figure at $34000.0, down 88.28% from the prior year.
- Other Accumulated Expenses was $34000.0 for Q4 2025 at Talphera, down from $290000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $1.2 million in Q4 2021, with the low at $34000.0 in Q4 2025.
- Average Other Accumulated Expenses over 5 years is $430400.0, with a median of $319000.0 recorded in 2023.
- The sharpest annual moves came in 2021 and 2025: Other Accumulated Expenses soared 39.14% in 2021, then plunged 88.28% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $1.2 million in 2021, then tumbled by 70.58% to $343000.0 in 2022, then dropped by 7.0% to $319000.0 in 2023, then fell by 9.09% to $290000.0 in 2024, then slumped by 88.28% to $34000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $34000.0 (Q4 2025), $290000.0 (Q4 2024), and $319000.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 319,000.00 |
| Dec 31, 2022 | 343,000.00 |
| Dec 31, 2021 | 1.17 Mn |
| Dec 31, 2020 | 838,000.00 |
| Dec 31, 2019 | 980,000.00 |
| Dec 31, 2018 | 695,000.00 |
| Dec 31, 2017 | 842,000.00 |
| Dec 31, 2016 | 821,000.00 |
| Dec 31, 2015 | 808,000.00 |
| Dec 31, 2014 | 615,000.00 |
| Sep 30, 2011 | 103,000.00 |
| Jun 30, 2011 | 151,000.00 |